Cited by 405Gastrointestinal motility and disordersInfant Health and DevelopmentPsychosomatic Disorders and Their Treatments

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Ford, Alexander C, Quigley, Eamonn M M, Lacy, Brian E, Lembo, Anthony J, Saito, Yuri A, Schiller, Lawrence R, Soffer, Edy E, Spiegel, Brennan M R, Moayyedi, Paul·2014·American Journal of Gastroenterology

DOI 10.1038/ajg.2014.148

Open this paper in CoChat — free account

Abstract

OBJECTIVES: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence relating to the treatment of this condition with antidepressants and psychological therapies continues to accumulate. METHODS: We performed an updated systematic review and meta-analysis of randomized controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Trials recruiting adults with IBS, which compared antidepressants with placebo, or psychological therapies with control therapy or "usual management," were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). RESULTS: The search strategy identified 3,788 citations. Forty-eight RCTs were eligible for inclusion: thirty-one compared psychological therapies with control therapy or "usual management," sixteen compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Ten of the trials of psychological therapies, and four of the RCTs of antidepressants, had been published since our previous meta-analysis. The RR of IBS symptom not improving with antidepressants vs. placebo was 0.67 (95% CI=0.58-0.77), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms not improving with psychological therapies was 0.68 (95% CI=0.61-0.76). Cognitive behavioral therapy, hypnotherapy, multicomponent psychological therapy, and dynamic psychotherapy were all beneficial. CONCLUSIONS: Antidepressants and some psychological therapies are effective treatments for IBS. Despite the considerable number of studies published in the intervening 5 years since we last examined this issue, the overall summary estimates of treatment effect have remained remarkably stable.

Integrity signals

Registry

Crossref · 10.1038/ajg.2014.148

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
U. S. Householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Self-citation
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramèr, M. R., Nye, B., Carroll, D., Wiffen, P. J., & Moore, A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 926
Antidepressants for neuropathic pain
Saarto, T., & Wiffen, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005454.pub2 · Cited by 806

Show all 72 references

Research works printed but not linked: 3

Bergmann, 1991, Die Therapie Des Colon Irritabile Mit Trimipramin (Herphonal) - Eine Kontrollierte Studie., Z Klin Med, 46, 1621
Boerner, 1988, Wirksamkeit Und Vertraglichkeit Eines Antidepressivuns Beim Colon Irritabile., Therapiewoche, 38, 201
Vij, 1991, Effect of antidepressant drug (Doxepin) on irritable bowel syndrome patients., Indian J Psychiatry, 33, 243

Sorted by citations

Bowel Disorders
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
“Seven trials were included, demonstrating benefits of selective serotonin reuptake inhibitors over placebo for overall IBS symptoms.(65) A number of clinical characteristics, including the predominant stool complaint, thepresenceof insomnia, or comorbidanxiety, can influence the choice of antidepressant in an individu…”
BackgroundSelf-citation
Irritable bowel syndrome: a clinical review.
Chey, W., Kurlander, J. E., & Eswaran, S. (2015) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2015.0954 · Cited by 748
Irritable bowel syndrome
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M. D., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 1,102
Self-citation
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893
“They can also include techniques that alter pain perception by activating brain centers that downregulate sensations from the gut and increase psychological flexibility, acceptance, and self-efficacy (245,246).”
BackgroundSelf-citation
Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
Cherry, S. R., Jones, T., Karp, J. S., Qi, J., Moses, W. W., & Badawi, R. D. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.184028 · Cited by 763
“This link is further reinforced by the fact that cognitive behavioral therapy has been shown to be effective for a range of gastrointestinal disorders, most notably irritable bowel syndrome (38).”
Background
ACG and CAG Clinical Guideline: Management of Dyspepsia
Moayyedi, P., Lacy, B. E., Andrews, C. N., Enns, R., Howden, C. W., & Vakil, N. B. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.154 · Cited by 704
Self-citation
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 664
Self-citation
Pathophysiology of irritable bowel syndrome
Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30023-1 · Cited by 590
Self-citation
Rome criteria and a diagnostic approach to irritable bowel syndrome
Lacy, B., & Patel, N. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6110099 · Cited by 575
“This should improve visceral pain and may slow colonic transit to some degree [19].”
BackgroundSelf-citation
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut−Brain Interaction): A Rome Foundation Working Team Report
Drossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Self-citation
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis
Ford, A. C., Lacy, B. E., Harris, L. A., Quigley, E. M. M., & Moayyedi, P. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0222-5 · Cited by 467
“Previous meta-analyses by our group [20, 21], conducted to inform the American College of Gastroenterology’s (ACG) monograph on the management of IBS [22, 23], have suggested that both antidepressants and psychological therapies are effective treatments for IBS.”
Self-citation
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., & Quigley, E. M. M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0084-x · Cited by 388
Self-citation
The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract
Bonaz, B., Sinniger, V., & Pellissier, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01452 · Cited by 405
“Psychotherapy, like cognitive-behavioral therapy and complementary medicine like hypnosis, are known to improve vagal tone (90, 168, 169), and could be of interest in the treatment of IBS symptoms.”
Background
The mucosal immune system: master regulator of bidirectional gut-brain communications
Powell, N., Walker, M. M., & Talley, N. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.191 · Cited by 379
Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.
Camilleri, M. (2021) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2020.22532 · Cited by 329
Management of functional somatic syndromes and bodily distress
Henningsen, P., Zipfel, S., Sattel, H., & Creed, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000484413 · Cited by 335
Sex-gender differences in irritable bowel syndrome
Kim, Y. S., & Kim, N. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18082 · Cited by 322
“Psychotherapy Did not conduct separate analyses by sex.(11,111,112)”
BackgroundMethod
Evidence that independent gut‐to‐brain and brain‐to‐gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1‐year population‐based prospective study
Koloski, N. A., Jones, M., & Talley, N. J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13738 · Cited by 318
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Lembo, A., Pimentel, M., Rao, S. S., Schoenfeld, P., Cash, B., Weinstock, L. B., Paterson, C., Bortey, E., & Forbes, W. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.003 · Cited by 310
“Antidepressants, such as tricyclic agents, although not approved for the treatment of IBS-D, have been considered efficacious for reducing abdominal pain and global IBS symptoms in patients with IBS.(2) However, data on the efficacy of these agents specifically for treatment of IBS-D are limited.”
BackgroundInfluentialSelf-citation
The low FODMAP diet in the management of irritable bowel syndrome: an evidence‐based review of FODMAP restriction, reintroduction and personalisation in clinical practice
Whelan, K., Martin, L. D., Staudacher, H. M., & Lomer, M. C. E. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12530 · Cited by 322
“Non-dietary treatment options for IBS include cognitive behavioural therapy and hypnotherapy ((91,92)).”
Background
Comparing Skype (video calling) and in-person qualitative interview modes in a study of people with irritable bowel syndrome – an exploratory comparative analysis
Krouwel, M., Jolly, K. B., & Greenfield, S. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0867-9 · Cited by 408
Towards a systems view of IBS
Mayer, E. A., Labus, J. S., Tillisch, K., Cole, S. W., & Baldi, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.121 · Cited by 293
Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis
Gracie, D. J., Irvine, A. J., Sood, R., Mikocka-Walus, A., Hamlin, P. J., & Ford, A. C. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30206-0 · Cited by 271
Self-citation
The neurobiology of irritable bowel syndrome
Mayer, E. A., Ryu, H. J., & Bhatt, R. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01972-w · Cited by 304
“Stressful and traumatic events during early life increase chances of developing IBS, and psychosocial stressors in adulthood play a crucial role during the first onset, symptom flare, and perceived severity of the symptoms [80]; centrally targeted pharmacological treatments and cognitive behavioral strategies have bee…”
Background
European society of neurogastroenterology and motility guidelines on functional constipation in adults
Serra, J., Pohl, D., Azpiroz, F., Chiarioni, G., Ducrotté, P., Gourcerol, G., Hungin, A. P. S., Layer, P., Mendive, J., Pfeifer, J., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13762 · Cited by 244
Probiotics in Disease Prevention and Treatment
Liu, Y., Tran, D. Q., & Rhoads, J. M. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1121 · Cited by 238
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)
Moayyedi, P., Andrews, C. N., MacQUEEN, G. M., Korownyk, C. S., Marsiglio, M., Graff, L. A., Kvern, B. L., Lazarescu, A., Liu, L., Paterson, W. G., et al. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwy071 · Cited by 216
“In IBS trials, the doses of SSRIs were similar to those used to treat depression, whereas the doses of TCAs were considerably lower than therapeutic antidepressant doses (121).”
BackgroundMethodInfluentialSelf-citation
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome
Lackner, J. M., Jaccard, J., Keefer, L., Brenner, D. M., Firth, R. S., Gudleski, G. D., Hamilton, F. A., Katz, L. A., Krasner, S. S., Ma, C.-X., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.063 · Cited by 191
Chronic Diarrhea and Constipation Are More Common in Depressed Individuals
Ballou, S., Katon, J. M., Singh, P., Rangan, V., Lee, H. N., McMahon, C., Iturrino, J., Lembo, A. J., & Nee, J. W. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.03.046 · Cited by 183
Self-citation
The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota–gut–brain axis perspective
Leigh, S., Uhlig, F., Wilmes, L., Sánchez-Díaz, P., Gheorghe, C. E., Goodson, M. S., Kelley‐Loughnane, N., Hyland, N. P., Cryan, J. F., & Clarke, G. A. (2023) · The Journal of Physiology · doi:10.1113/jp281951 · Cited by 201
Best practice update: Incorporating psychogastroenterology into management of digestive disorders
Keefer, L., Palsson, O. S., & Pandolfino, J. E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.045 · Cited by 173
“IBS patients in particular often appreciate hearing that there are more than 30 randomized controlled trials for CBT and 11 for hypnosis in IBS alone, with numbers needed to treat between 2 and 4.(12) These therapies have also been used successfully across a spectrum of digestive diseases, including non-cardiac chest…”
Background
Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis
Black, C. J., Yuan, Y., Selinger, C. P., Camilleri, M., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30324-3 · Cited by 171
Self-citation
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis
Black, C. J., Burr, N. E., Quigley, E. M. M., Moayyedi, P., Houghton, L. A., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.021 · Cited by 166
Self-citation
Dietary and pharmacological treatment of abdominal pain in IBS
Camilleri, M., & Boeckxstaens, G. E. (2017) · Gut · doi:10.1136/gutjnl-2016-313425 · Cited by 165
Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis
Person, H., & Keefer, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110209 · Cited by 158
“While rigorous investigation of many of these agents is lacking in DGBI, there has been evidence to support the use of tricyclic antidepressants to manage pain in both IBS and FD (Ford et al., 2014; Talley et al., 2015).”
Background
Irritable bowel syndrome: the clinical approach.
Adriani, A., Ribaldone, D., Astegiano, M., Durazzo, M., Saracco, G., & Pellicano, R. (2018) · Panminerva Medica (Testo stampato) · doi:10.23736/s0031-0808.18.03541-3 · Cited by 88
Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4632 · Cited by 143
Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis
Laird, K. T., Tanner‐Smith, E. E., Russell, A. C., Hollon, S. D., & Walker, L. S. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.11.001 · Cited by 148
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency
Pinto-Sánchez, M. I., Ford, A. C., Avila, C., Verdu, E. F., Collins, S. M., Morgan, D., Moayyedi, P., & Berčík, P. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.128 · Cited by 142
Self-citation
New treatments and therapeutic targets for IBS and other functional bowel disorders
Simrén, M., & Tack, J. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0034-5 · Cited by 150
Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis
Laird, K. T., Tanner-Smith, E. E., Russell, A. C., Hollon, S. D., & Walker, L. S. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.020 · Cited by 135
European Crohn’s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease
Torres, J., Ellul, P., Langhorst, J., Mikocka‐Walus, A. A., Acosta, M. B., Basnayake, C., Ding, N. S., Gilardi, D., Katsanos, K. H., Moser, G., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz051 · Cited by 143
Review article: treatment options for functional dyspepsia
Masuy, I., Oudenhove, L. V., & Tack, J. F. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15191 · Cited by 140
Management of functional gastrointestinal disorders
Fikree, A., & Byrne, P. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0980 · Cited by 137
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice
Moayyedi, P., Mearin, F., Azpiroz, F., Andresen, V., Barbara, G., Corsetti, M., Emmanuel, A., Hungin, A. P. S., Layer, P., Stanghellini, V., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617731968 · Cited by 135
“In a meta-analysis of randomised controlled trials of patients with IBS treated with antidepressants, these agents as a class were shown to improve abdominal pain along with global IBS symptoms.(14) The symptomatic benefit of antidepressants in IBS seems to be unrelated to the presence or improvement of coexistent dep…”
Self-citation
Management Options for Irritable Bowel Syndrome
Camilleri, M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.032 · Cited by 140
Age, Gender, and Women’s Health and the Patient
Houghton, L. A., Heitkemper, M. M., Crowell, M. D., Emmanuel, A. V., Halpert, A. D., McRoberts, J. A., & Toner, B. B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.017 · Cited by 125
Opioid misuse in gastroenterology and non-opioid management of abdominal pain
Szigethy, E., Knisely, M., & Drossman, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.141 · Cited by 117
“Ford et al.(129) (meta-analysis) 7 RCTs (356 patients with IBS) SSRIs (citalopram, fluoxetine, imipramine, paroxetine) versus placebo 6–12 Global IBS symptoms or abdominal pain • 45.”
Background
Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights
Kinsinger, S. W. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s120817 · Cited by 132
Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial
Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., Weusten, B. L. A. M., Whorwell, P. J., & de Wit, N. J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30310-8 · Cited by 126
Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating
Patel, P., Bercik, P., Morgan, D. G., Bolino, C., Pintos‐Sanchez, M. I., Moayyedi, P., & Ford, A. C. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13074 · Cited by 115
Self-citation
Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease
Peters, S. L., Muir, J. G., & Gibson, P. R. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13202 · Cited by 113
“The majority of these have been recently subjected to systematic review and meta-analysis.(18) Detailed analysis of the gastrointestinal outcomes from those RCTs is shown in”
Background
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Peppas, S., Pansieri, C., Piovani, D., Danese, S., Peyrin‐Biroulet, L., Tsantes, A. G., Brunetta, E., Tsantes, A. Ε., & Bonovas, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030377 · Cited by 116
Second Asian Consensus on Irritable Bowel Syndrome
Gwee, K., Gonlachanvit, S., Ghoshal, U. C., Chua, A. S. B., Miwa, H., Wu, J. C. Y., Bak, Y., Lee, O. Y., Lu, C., Park, H., et al. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19041 · Cited by 112
“67 and NNT of 4.(186) The quality of the data appeared to be better for tricyclic antidepressant (TCA) than selective serotonin reuptake inhibitor”
Background
The Efficacy, Safety and Applications of Medical Hypnosis: A Systematic Review of Meta-analyses
Häuser, W., Hagl, M., Schmierer, A., & Hansen, E. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0289 · Cited by 110
“…et al. 2014 (e11) Bernardy et al. 2011 (e12) Birnie et al. 2014 (e13) Bowker et al. 2014 (e14) Enck et al. 2010 (e15) Flammer et al. 2007 (e16) Ford et al. 2014 (e17) Glazener et al. 2005 (e18) Huang et al. 2011 (e19) Köllner et al. 2012 (e20) Lee et al. 2014 (e21) Richardson et al. 2007…”
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation
Savarino, V., Pace, F., Scarpignato, C., & the Esoxx Study Group (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13914 · Cited by 109
“Reflux inhibitors represent a promise unfulfilled,(64) effective prokinetics are lacking 65 and antidepressants, despite being effective in selected patients,(66) give rise to adverse events in up to 32% of patients.(67)”
Background
Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis
Xie, C., Tang, Y., Wang, Y., Yu, T., Wang, Y., Jiang, L., & Lin, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127815 · Cited by 106
Irritable bowel syndrome in children: Current knowledge, challenges and opportunities
Devanarayana, N. M., & Rajindrajith, S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i21.2211 · Cited by 109
Review article: the many potential roles of intestinal serotonin (5‐hydroxytryptamine, 5‐ HT ) signalling in inflammatory bowel disease
Coates, M. D., Tekin, I., Vrana, K. E., & Mawe, G. M. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14226 · Cited by 107
Functional somatic symptoms
Roenneberg, C., Sattel, H., Schaefert, R., Henningsen, P., & Hausteiner-Wiehle, C. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0553 · Cited by 111
Does central sensitization help explain idiopathic overactive bladder?
Reynolds, W. M., Dmochowski, R. R., Wein, A. J., & Bruehl, S. P. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.95 · Cited by 99
Pathways in gut-brain communication: Evidence for distinct gut-to-brain and brain-to-gut syndromes
Keightley, P., Koloski, N. A., & Talley, N. J. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415569801 · Cited by 97
“Clinical evidence for a brain-gut directionality comes from the responsiveness of many FGID to brain orientated therapies such as hypnosis, psychodynamic and cognitive-behavioural therapy (Boyce et al., 2003; Ford et al., 2014).”
Background
The Place of Stress and Emotions in the Irritable Bowel Syndrome
Sonia Pellissier, A., & Bonaz, B. L. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.005 · Cited by 102
Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease
Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0021-z · Cited by 98
Self-citation
Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome
Rutten, J. M. T. M., Vlieger, A. M., Frankenhuis, C., George, E. K., Groeneweg, M., Norbruis, O. F., Ten, W. T. A., van Wering, H. M., Dijkgraaf, M. G. W., Merkus, M. P., et al. (2017) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2017.0091 · Cited by 97
Antidepressants in Inflammatory Bowel Disease: A Systematic Review
Macer, B. J. D., Prady, S. L., & Mikocka-Walus, A. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001059 · Cited by 92
Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence
Palsson, O. S. (2015) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2015.1039114 · Cited by 94
“The accumulation of this critical mass of hypnotherapy research in adult IBS has played a substantial role—along with the even larger and equally impressive body of research on cognitive-behavioral therapy for the disorder (Ford et al., 2014; Palsson & Whitehead, 2013)—in gaining psychological treatments the status of…”
Background
Antidepressants in inflammatory bowel disease
Mikocka-Walus, A., Ford, A. C., & Drossman, D. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0259-y · Cited by 93
Self-citation
Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trial
Thakur, E. R., Holmes, H. J., Lockhart, N. A., Carty, J. N., Ziadni, M. S., Doherty, H. K., Lackner, J. M., Schubiner, H. H., & Lumley, M. A. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13143 · Cited by 94
Irritable Bowel Syndrome
Weaver, K. R., Melkus, G. D., & Henderson, W. A. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000520253.57459.01 · Cited by 98
Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis
Riggott, C., Mikocka-Walus, A., Gracie, D. J., & Ford, A. C. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00186-3 · Cited by 83
Self-citation
Management of the multiple symptoms of irritable bowel syndrome.
Simrén, M., Törnblom, H., Palsson, O., & Whitehead, W. (2017) · The Lancet Gastroenterology and Hepatology · doi:10.1016/s2468-1253(16)30116-9 · Cited by 70
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome
Jin, D., Cao, H., Xu, M., Wang, S.-N., Wang, Y., Yan, F., & Wang, B. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8137 · Cited by 82
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
Mermelstein, J., Mermelstein, A. C., & Chait, M. M. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s121056 · Cited by 84
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016
Layer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 81
Health-Related Quality of Life in Irritable Bowel Syndrome
Cassar, G. E., Youssef, G. J., Knowles, S. R., Moulding, R., & Austin, D. (2020) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000530 · Cited by 80
“…Prokop, Sood, & Murad, 2015; Ford, Forman, Bailey, Axon, & Moayyedi, 2008; Ford, Lacy, Harris, Quigley, & Moayyedi, 2018a; Ford et al., 2018b; Ford et al., 2014b; Lackner, Mesmer, Morley, Dowzer, & Hamilton, 2004; Laird, Tanner-Smith, Russell, Hollon, & Walker, 2016; Thakur et al., 2018;…”
BackgroundInfluential
Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia
Lacy, B. E., Saito, Y. A., Camilleri, M., Bouras, E. P., DiBaise, J. K., Herrick, L. M., Szarka, L. A., Tilkes, K. E., Zinsmeister, A. R., & Talley, N. J. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.458 · Cited by 74
Self-citation
Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation
Zhang, J., Liu, J., Zhu, S., Fang, Y., Wang, B., Jia, Q., Hao, H., Kao, J. Y., He, Q., Song, L., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00601-4 · Cited by 75
Treating empty nose syndrome as a somatic symptom disorder
Lemogne, C., Consoli, S. M., Limosin, F., & Bonfils, P. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.02.005 · Cited by 73
Physical comorbidities of post‐traumatic stress disorder in Australian Vietnam War veterans
McLeay, S. C., Harvey, W., Romaniuk, M., Crawford, D. H., Colquhoun, D. M., Young, R. M., Dwyer, M., Gibson, J. M., O’Sullivan, R., Cooksley, G., et al. (2017) · The Medical Journal of Australia · doi:10.5694/mja16.00935 · Cited by 78
Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol
Vasant, D. H., & Whorwell, P. J. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13573 · Cited by 78
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: A double-blind, randomised, placebo-controlled study
Preston, K., Krumian, R., Hattner, J., de Montigny, D., Stewart, M., & Gaddam, S. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0105 · Cited by 70
Integrated Psychological Care is Needed, Welcomed and Effective in Ambulatory Inflammatory Bowel Disease Management: Evaluation of a New Initiative
Lores, T. J., Goess, C., Mikocka‐Walus, A. A., Collins, K., Burke, A. L. J., Chur‐Hansen, A., Delfabbro, P., & Andrews, J. M. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz026 · Cited by 72
The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome
Windgassen, S., Moss‐Morris, R., Chilcot, J., Sibelli, A., Goldsmith, K., & Chalder, T. (2017) · British Journal of Health Psychology · doi:10.1111/bjhp.12250 · Cited by 67
New insights into irritable bowel syndrome: from pathophysiology to treatment
Hadjivasilis, A. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0428 · Cited by 76
“Interestingly, cognitive behavioral therapies, hypnotherapy and psychotherapy appear to be helpful in reducing global symptoms [113], most probably because of the gut–brain connection.”
Background
Citalopram for pediatric functional abdominal pain: a randomized, placebo‐controlled trial
Roohafza, H., Pourmoghaddas, Z., Saneian, H., & Gholamrezaei, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12444 · Cited by 69
A Systematic Review of Relaxation, Meditation, and Guided Imagery Strategies for Symptom Management in Heart Failure
Kwekkeboom, K. L., & Bratzke, L. C. (2015) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000274 · Cited by 70
Behavioural medicine and gastrointestinal disorders: the promise of positive psychology
Keefer, L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0001-1 · Cited by 71
Brain–Gut Axis
Khlevner, J., Park, Y., & Margolis, K. G. (2018) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2018.07.002 · Cited by 75
Central neuromodulators for treating functional GI disorders: a primer
Sobin, H. W., Heinrich, T. W., & Drossman, D. A. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.57 · Cited by 64
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2015) · Europe PMC (PubMed Central) · Cited by 68
A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults
Söderquist, F., Syk, M., Just, D., Novičić, Z. K., Rasmusson, A. J., Hellström, P. M., Ramklint, M., & Cunningham, J. L. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02940-2 · Cited by 66
“Studies have found ameliorated IBS symptoms with SSRI treatment, but also with tricyclic antidepressants (63, 64).”
Background
The Placebo Response in Pediatric Abdominal Pain-Related Functional Gastrointestinal Disorders: A Systematic Review and Meta-Analysis
Hoekman, D. R., Zeevenhooven, J., van Etten‐Jamaludin, F. S., Dekker, I. D., Benninga, M. A., Tabbers, M. M., & Vlieger, A. M. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.12.022 · Cited by 65
Randomised clinical trial: Tong‐Xie‐Yao‐Fang granules versus placebo for patients with diarrhoea‐predominant irritable bowel syndrome
Chen, M., Tang, T., Wang, Y., Shui, J., Xiao, X.-H., Lan, X., Yu, P., Zhang, C., Wang, S.-H., Yao, J., et al. (2018) · Alimentary Pharmacology and Therapeutics · doi:10.1111/apt.14817 · Cited by 62
“As initial treatment, dietary and lifestyle modification have variable effects on IBS-D, and their effects are often less than optimal.(7) Alosetron, one of the 5-HT3 antagonists, is effective for abdominal pain and discomfort, but it causes a dose-dependent increase in adverse events (constipation and ischaemic colit…”
Background
Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies
Zhang, Q., Wang, F., Geng, Q., Zheng, W., Ng, C. H., Ungvari, G. S., Yuan, Z., Mei, S., Wang, G., & Xiang, Y. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25001 · Cited by 64
“14), which is different from studies that found IBS-C/IBS-D with the largest effect size [18, 25, 26].”
BackgroundResult
Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders
Törnblom, H., & Drossman, D. A. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0664-3 · Cited by 67
Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions
Ghaffari, P., Shoaie, S., & Nielsen, L. K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03365-z · Cited by 60
“Antispasmodic drugs Pain Low Inhibition of muscarinic Ach receptors or block calcium ion channels, GI smooth muscle dry mouth, dizziness, and blurred vision [113, 114]”
Background
Pharmacologic Treatment in Functional Abdominal Pain Disorders in Children: A Systematic Review
Rexwinkel, R., de Bruijn, C. M. A., Gordon, M. A., Benninga, M. A., & Tabbers, M. M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-042101 · Cited by 55
Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
Flik, C. E., Bakker, L., Laan, W., van Rood, Y. R., Smout, A. J. P. M., & de Wit, N. J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i12.2223 · Cited by 56
Guidelines on the management of irritable bowel syndrome
Pietrzak, A. M., Skrzydło-Radomańska, B., Mulak, A., Lipiński, M., Malecka-Panas, E. I., Reguła, J., & Rydzewska, G. M. (2018) · Gastroenterology Review · doi:10.5114/pg.2018.78343 · Cited by 60

Authors: Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P.
Affiliations: University of Leeds (GB)
Houston Methodist (US)
Dartmouth–Hitchcock Medical Center (US)
Beth Israel Deaconess Medical Center (US)
Mayo Clinic (US)
Baylor University Medical Center (US)
University of Southern California (US)
VA Greater Los Angeles Healthcare System (US)
McMaster University (CA)
Corresponding author: Ford, Alexander C
ORCID: Ford, Alexander C
Quigley, Eamonn M M
Lacy, Brian E
Lembo, Anthony J
Saito, Yuri A
Schiller, Lawrence R
Soffer, Edy E
Spiegel, Brennan M R
Moayyedi, Paul
Venue: American Journal of Gastroenterology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-09
Volume: 109
Issue: 9
Pages: 1350-1365
ISSN: 0002-9270 (ISSN-L)
DOI: 10.1038/ajg.2014.148
OpenAlex: W2171220209
Cited by: 405
References: 72
Citations by year: 2026: 10 · 2025: 15 · 2024: 15 · 2023: 13 · 2022: 27 · 2021: 29 · 2020: 28 · 2019: 51 · 2018: 60 · 2017: 61 · 2016: 46 · 2015: 41 · 2014: 6
FWCI: 8.39
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: The American Journal of Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Funders: American College of Gastroenterology
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords: irritable bowel syndrome, antidepressants, psychotherapy, hypnotherapy, cognitive behavioral therapy, tricyclic antidepressants, selective serotonin reuptake inhibitors, psychodynamic psychotherapy, symptom remission, functional gastrointestinal disorders
MeSH terms: Antidepressive Agents, Antidepressive Agents, Tricyclic, Humans, Hypnosis, Psychotherapy, Relaxation Therapy, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks